| Caleb Christopher Gerhart, | |
|
2525 Court Dr, Gastonia, NC 28053 | |
| (704) 824-2000 | |
| Not Available |
| Full Name | Caleb Christopher Gerhart |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2525 Court Dr, Gastonia, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629231212 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2012-00799 (North Carolina) | Primary |
| Entity Name | Emergency Medicine Physicians Of Carteret County Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538108535 PECOS PAC ID: 0042122582 Enrollment ID: O20031103000502 |
News Archive
Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).
T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data today on the rapid and sensitive detection of five species of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group in Philadelphia, PA.
The New York Times on Wednesday examined how as "medical advances have allowed patients who might have died as children to survive into adulthood, the patients are falling into a void in a health care system that has yet to develop institutions for the young and 'medically fragile.'"
A Danish study provides 10-year absolute risk estimates for dementia specific to age, sex and common variation in the APOE gene, which may help identify high-risk individuals who potentially could benefit from early targeted prevention.
Scientists from Freie Universität Berlin and the NeuroCure Cluster of Excellence led by biochemist Volker Haucke in collaboration with colleagues from Australia and the Leibniz Institute for Molecular Pharmacology in Berlin have developed small molecules that inhibit the internalization of important signaling molecules but also of pathogenic organisms such as the immunodeficiency virus and bacteria into cells.
› Verified 3 days ago
| Entity Name | The Carolinas Emergency Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477508836 PECOS PAC ID: 2567486814 Enrollment ID: O20060125000577 |
News Archive
Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).
T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data today on the rapid and sensitive detection of five species of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group in Philadelphia, PA.
The New York Times on Wednesday examined how as "medical advances have allowed patients who might have died as children to survive into adulthood, the patients are falling into a void in a health care system that has yet to develop institutions for the young and 'medically fragile.'"
A Danish study provides 10-year absolute risk estimates for dementia specific to age, sex and common variation in the APOE gene, which may help identify high-risk individuals who potentially could benefit from early targeted prevention.
Scientists from Freie Universität Berlin and the NeuroCure Cluster of Excellence led by biochemist Volker Haucke in collaboration with colleagues from Australia and the Leibniz Institute for Molecular Pharmacology in Berlin have developed small molecules that inhibit the internalization of important signaling molecules but also of pathogenic organisms such as the immunodeficiency virus and bacteria into cells.
› Verified 3 days ago
| Entity Name | Emergency Medicine Physicians Of Mecklenburg County Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912232182 PECOS PAC ID: 3870635584 Enrollment ID: O20100119000374 |
News Archive
Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).
T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data today on the rapid and sensitive detection of five species of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group in Philadelphia, PA.
The New York Times on Wednesday examined how as "medical advances have allowed patients who might have died as children to survive into adulthood, the patients are falling into a void in a health care system that has yet to develop institutions for the young and 'medically fragile.'"
A Danish study provides 10-year absolute risk estimates for dementia specific to age, sex and common variation in the APOE gene, which may help identify high-risk individuals who potentially could benefit from early targeted prevention.
Scientists from Freie Universität Berlin and the NeuroCure Cluster of Excellence led by biochemist Volker Haucke in collaboration with colleagues from Australia and the Leibniz Institute for Molecular Pharmacology in Berlin have developed small molecules that inhibit the internalization of important signaling molecules but also of pathogenic organisms such as the immunodeficiency virus and bacteria into cells.
› Verified 3 days ago
| Entity Name | Observation Medicine Physicians Of Mecklenburg County Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982075388 PECOS PAC ID: 8022313832 Enrollment ID: O20160216001560 |
News Archive
Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).
T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data today on the rapid and sensitive detection of five species of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group in Philadelphia, PA.
The New York Times on Wednesday examined how as "medical advances have allowed patients who might have died as children to survive into adulthood, the patients are falling into a void in a health care system that has yet to develop institutions for the young and 'medically fragile.'"
A Danish study provides 10-year absolute risk estimates for dementia specific to age, sex and common variation in the APOE gene, which may help identify high-risk individuals who potentially could benefit from early targeted prevention.
Scientists from Freie Universität Berlin and the NeuroCure Cluster of Excellence led by biochemist Volker Haucke in collaboration with colleagues from Australia and the Leibniz Institute for Molecular Pharmacology in Berlin have developed small molecules that inhibit the internalization of important signaling molecules but also of pathogenic organisms such as the immunodeficiency virus and bacteria into cells.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caleb Christopher Gerhart, 2525 Court Dr, Gastonia, NC 28053 Ph: (704) 824-2000 | Caleb Christopher Gerhart, 2525 Court Dr, Gastonia, NC 28053 Ph: (704) 824-2000 |
News Archive
Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS).
T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data today on the rapid and sensitive detection of five species of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group in Philadelphia, PA.
The New York Times on Wednesday examined how as "medical advances have allowed patients who might have died as children to survive into adulthood, the patients are falling into a void in a health care system that has yet to develop institutions for the young and 'medically fragile.'"
A Danish study provides 10-year absolute risk estimates for dementia specific to age, sex and common variation in the APOE gene, which may help identify high-risk individuals who potentially could benefit from early targeted prevention.
Scientists from Freie Universität Berlin and the NeuroCure Cluster of Excellence led by biochemist Volker Haucke in collaboration with colleagues from Australia and the Leibniz Institute for Molecular Pharmacology in Berlin have developed small molecules that inhibit the internalization of important signaling molecules but also of pathogenic organisms such as the immunodeficiency virus and bacteria into cells.
› Verified 3 days ago
Dr. Ian Oluremilekun Cole, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 704-834-2000 | |
Dino A Graziano, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3104 Love Ct, Gastonia, NC 28056 Phone: 704-813-9463 | |
Kyle Roedersheimer, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 704-834-2000 | |
Timothy F Corvino, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 330-493-4443 Fax: 330-493-8677 | |
Dr. Karen B Bentley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 704-834-2662 Fax: 704-834-2686 | |
Andrew J Moore, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2525 Court Drive Gastonia Physician Services, Pllc, Gastonia, NC 28054 Phone: 704-834-3471 | |
Dr. Renee Annette Fulbright, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2525 Court Dr, Department Of Emergency Medicine Gaston Memorial Hosp., Gastonia, NC 28054 Phone: 704-834-2266 |